Jeffery Moscow
Pediatric Hematology-Oncology · Lexington, KYNPI 1205853637
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, AstraZeneca.
Across 2 payments — averaging $31.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$62
Across 8 payments — averaging $1,740,691 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$13.9M
- Novartis$2K
What the payments were for
- Food & beverage$62100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $62 |
How this compares
Too few pediatric hematology-oncology providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Other pediatric hematology-oncology in Lexington
- Vlad RadulescuLexington$24K
- Lars WagnerLexington$9K
- Sherry BayliffLexington$83
- John D OrazioLexington$37
- Caryn SorgeLexington$0
- Ashok RajLouisville$165K
- Michael FergusonLouisville$3K
- Kerry McGowanLouisville$1K
- Esther KnappLouisville$1K
- William TseLouisville$585
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.